Protein Called MITOL Linked to Parkinson’s, Research Suggests
Parkinson’s disease-related protein Parkin may rely on another protein called MITOL to repair damaged mitochondria, the small organelles…
Articles by Catarina Silva, MSc
Protein Works to Spread Toxic Clumps in Brain and Promote Parkinson’s, Study Finds
Connexin-32 — a protein found in small channels between nerve cells and involved in cell-to-cell communication — works to progress …
Plant Chemical Chrysin May Protect Against Parkinson’s-related Changes, Mouse Study Suggests
Chrysin, a chemical commonly found in plants, may ease behavioral, cognitive, and neurochemical changes in Parkinson’s disease, according to…
Specific BDNF Mutation May Be Linked to Higher Risk of Cognitive Impairment in Parkinson’s, Study Suggests
One amino acid change in the brain-derived neurotrophic factor (BDNF) gene, which provides instructions for a protein important to…
‘ParkinSong’ and Other Song Therapy Programs May Help Preserve Speech, Study Says
Intensive singing interventions have the potential to increase vocal loudness, respiratory muscle strength, and voice-related quality of life in people…
#AANAM – Data Recorded from PKG Wearable Device May Help Clinicians Choose Better Treatment, Study Says
A wearable device called Personal KinetiGraph (PKG) can continuously and objectively monitor motor symptoms in people with Parkinson’s…
#AANAM – Promising Blood Pressure Medicine Fails to Slow Parkinson’s Progression, Trial Results Show
In contrast to what was observed in mice, a hypertension medicine called Dynacirc (isradipine) failed to slow Parkinson’s disease…
#AANAM – L-DOPA Nasal Delivery System May Offer New Way to Manage Parkinson’s OFF Episodes
Impel NeuroPharma has developed an inhaler to administrate a powder formulation of levodopa (L-DOPA) so people with…
Treatment with Intranasal Insulin May Improve Verbal Fluency and Motor Function, Early Study Shows
Treatment with intranasal insulin — which is atomized into a spray and inhaled through the nose — may ease…
ISCO’s Phase 1 Trial Testing Neural Stem Cell Therapy Completes Patient Enrollment
Patient enrollment and dosing is now complete for International Stem Cell Corporation’s (ISCO) Phase 1 trial testing its ISC-hpNSC…